Ozempic 8 mg/3 mL (2.68 mg/mL) prefilled pen that delivers 2 mg per injection Images
Generic Name: semaglutide
This medication has been identified as Ozempic 8 mg/3 mL (2.68 mg/mL) prefilled pen that delivers 2 mg per injection. It is supplied by Novo Nordisk.
Ozempic is used in the treatment of Cardiovascular Risk Reduction; Type 2 Diabetes; Chronic Kidney Disease and belongs to the drug class GLP-1 Agonists (Incretin Mimetics). Ozempic 8 mg/3 mL (2.68 mg/mL) prefilled pen that delivers 2 mg per injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Ozempic
- Generic Name
- semaglutide
- Strength
- 8 mg/3 mL (2.68 mg/mL) prefilled pen that delivers 2 mg per injection
- Availability
- Prescription only
- Drug Class
- GLP-1 Agonists (Incretin Mimetics)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novo Nordisk
- National Drug Code (NDC)
- 00169-4772
More about Ozempic (semaglutide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,441)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: GLP-1 Agonists (Incretin Mimetics)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.